BCV
AUPH icon

Banque Cantonale Vaudoise’s Aurinia Pharmaceuticals AUPH Stock Holding History

Banque Cantonale Vaudoise’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,892
Closed -$23K – 799
2025
Q1 		$23K Buy
+2,892
New +$23.4K ﹤0.01% 762
2024
Q3 		$71K Hold
9,684
– – ﹤0.01% 586
2024
Q2 		$55K Buy
9,684
+5,410
+127% +$28.5K ﹤0.01% 778
2024
Q1 		$21K Sell
4,274
-13,229
-76% -$89.7K ﹤0.01% 875
2023
Q4 		$157K Sell
17,503
-4,471
-20% -$36.8K 0.01% 619
2023
Q3 		$171K Buy
21,974
+5,300
+32% +$51.8K 0.01% 713
2023
Q2 		$161K Sell
16,674
-836
-5% -$8.68K 0.01% 763
2023
Q1 		$192K Sell
17,510
-6,556
-27% -$57.8K 0.01% 710
2022
Q4 		$104K Sell
24,066
-3,311
-12% -$19.2K 0.01% 850
2022
Q3 		$205K Buy
27,377
+3,286
+14% +$28.4K 0.01% 709
2022
Q2 		$242K Buy
24,091
+244
+1% +$2.73K 0.01% 686
2022
Q1 		$296K Sell
23,847
-7,288
-23% -$113K 0.01% 705
2021
Q4 		$712K Buy
31,135
+16,399
+111% +$389K 0.03% 493
2021
Q3 		$326K Buy
14,736
+8,289
+129% +$132K 0.01% 692
2021
Q2 		$84K Hold
6,447
– – ﹤0.01% 984
2021
Q1 		$84K Sell
6,447
-129
-2% -$1.87K ﹤0.01% 947
2020
Q4 		$91K Sell
6,576
-156
-2% -$2.27K 0.01% 860
2020
Q3 		$99K Buy
6,732
+22
+0.3% +$319 0.01% 828
2020
Q2 		$109K Sell
6,710
-216
-3% -$3.46K 0.01% 766
2020
Q1 		$100K Buy
+6,926
New +$122K 0.01% 768

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Banque Cantonale Vaudoise's AUPH Position: Q2 2025 in Review

Banque Cantonale Vaudoise sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 2,892 shares — an estimated $23K sold.

Banque Cantonale Vaudoise first reported a position in AUPH in Q1 2020 and held it in 20 quarters. The position peaked at $712K in Q4 2021. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • Banque Cantonale Vaudoise reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 2,892 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $23K.
  • Banque Cantonale Vaudoise first reported a position in Aurinia Pharmaceuticals in Q1 2020 and held it in 20 quarters.
  • Banque Cantonale Vaudoise's Aurinia Pharmaceuticals position peaked at $712K in Q4 2021.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2025, filed 11 Aug 2025.